Company profile
Precision Cardiovascular
Innovative solutions for the remote management of chronic cardiovascular disease, the leading cause of death globally
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 May 2025 to 30 Apr 2026
PCV aims to revolutionize chronic-disease-management by enhancing the quality-of-patient-information sent automatically to cardiologists, thereby reducing their workload and improving care for the growing population of patients with chronic cardiovascular conditions. This will improve diagnostic accuracy, reduce the frequency of clinical interventions, an...
1 Jul 2024 to 31 Dec 2025
Congestive heart-failure (CHF) is a progressive condition suffered by 60 million patients worldwide in which heart muscle weakness restricts patient activity and reduces life expectancy. Treatment involves high health service costs. CHF patients suffer a series of acute destabilisation episodes, progressively damaging the heart and causing distress and ho...
